Fraser Mary Clare 4

What Happened

• Mary Clare Fraser, SVP & Chief Human Resources Officer of STERIS plc, received equity awards dated June 2, 2026: 3,009 ordinary shares (awarded at $0) and a derivative award covering 10,492 shares (awarded at $0). On the same date, 591 vested shares were withheld to satisfy tax withholding obligations, valued at $209.76 per share for a total of $123,968.
• These transactions are award/grant activity (not an open-market purchase). The 591-share disposition is a tax withholding (routine) rather than a voluntary sale for investment purposes.

Key Details

• Transaction dates: June 2, 2026; Form 4 filed June 4, 2026 (timely filing).
• Prices and values: 591 shares withheld at $209.76 each = $123,968. Awards were granted at $0 (typical for RSUs/options).
• Shares owned after transaction: Not specified in the filing excerpt provided.
• Notable footnotes:
  • F1: 7,554 ordinary shares remain subject to restrictions with scheduled lapse dates between June 2026 and June 2029 (schedule provided in filing).
  • F2: The 591 shares were withheld from 2,028 restricted shares that vested on June 2, 2026; withholding value determined using NYSE close price on that date.
  • F3: The 10,492-share derivative award becomes exercisable in four installments of 2,623 shares on June 2, 2027; June 2, 2028; June 4, 2029; and June 3, 2030.
• Transaction codes: A = Award/Grant; F = Tax withholding.

Context

• The 10,492-share derivative grant is an option-style award with multi-year exercisability (see F3). The withholding of 591 vested shares to cover taxes is a common administrative step (a cashless-type withholding) and does not necessarily reflect a discretionary sale by the insider. These awards and withholdings are routine compensation events for executives.